Raf 1-ERK cross-talk in Arteriogenesis
Raf 1-ERK cross-talk in Arteriogenesis
批准号:
8250615
负责人:
Michael Simons
金额:
$48.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-10 至 2017-01-31
关键词:
AdultArteriesAtherosclerosisBindingBiologicalBlood CirculationBlood VesselsCardiovascular systemCerebrumCholesterolClinicalCollaborationsCoronaryDataDefectDevelopmentDiabetes MellitusDiseaseDown-RegulationEndothelial CellsEphrin-B2EventFailureFunctional disorderGenesGoalsImpairmentInstructionMAPK3 geneMaintenanceMediatingMediator of activation proteinModelingMolecularMorbidity - disease rateMusNeuropilin-1PIK3CG genePathway interactionsPeripheral Vascular DiseasesPhosphorylationPlayProcessProto-Oncogene Proteins c-aktRelative (related person)Research DesignRoleSignal PathwaySignal TransductionStructureTimeTunica AdventitiaVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factorscombathuman FRAP1 proteinhypercholesterolemiainsightmortalitymutantnew growthnotch proteinnovel therapeutic interventionnovel therapeuticsreceptorresearch studyresponseshear stressthrombospondin 2tooltraffickingtranscription factortreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
Arteriogenesis is the process of formation of new arterial blood vessels during development or in the adult circulation. In development it entails formation of new endothelial vascular structures with arterial identity as defined by expression of key markers such ephrin B2 and neuropilin 1 followed by acquisition of the media
and adventitia. In the adult circulation new arteries arise either by expansion of the pre-existing arterial vascular structures or de novo. Deletion of VEGF, its receptor VEGFR2 or key intracellular signaling mediators results in failure of arterial vasculature development. Defective arteriogenesis is noted in other setting including deletion of eNOS or in disease states such as diabetes and hypercholesterolemia and this
failure contributes greatly to morbidity u and mortality associated with these diseases. Nevertheless, the entire process is little understood and there are no currently successful approaches to deal with its defects in clinical settings. Understanding of molecular mechanism regulating arteriogenesis would be of great benefit
to our understanding of pathobiology of major cardiovascular illnesses and to development of new therapeutic approaches to combat them.
In this project we propose to focus on a newly discovered interaction between PI3K/Akt and ERK signaling pathways that appears to control arterial fate determination. Specifically we will 1) establish biological significance of Rafl SA-mediated decoupling of ERK and Akt signaling during development and in the normal vasculature; 2) Determine biological significance of Rafl SA-mediated decoupling of ERK and Akt signaling in impaired arteriogenesis settings and 3) dissect how endothelial dysfunction alters VEGFR2 signaling in hypercholesterolemic conditions and study whether ERK activation mitigates this defect. Taken together, this set of experiments will provide a comprehensive look at this critical arterial fate-determining signaling cascade.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ischemia/Reperfusion injury and Myocardial edema
-
批准号:10718260
-
项目类别:
-
资助金额:$61.03万
-
财政年份:2023
-
负责人:Michael Simons
-
依托单位:
Vascular smooth muscle cell heterogeneity and disease
-
批准号:10356855
-
项目类别:
-
资助金额:$83.06万
-
财政年份:2021
-
负责人:Michael Simons
-
依托单位:
Vascular smooth muscle cell heterogeneity and disease
-
批准号:10559596
-
项目类别:
-
资助金额:$83.11万
-
财政年份:2021
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:10192382
-
项目类别:
-
资助金额:$191.79万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
ERK signaling in arteriogenesis
-
批准号:10433818
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Administrative Core
-
批准号:10433815
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Administrative Core
-
批准号:10192383
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8424224
-
项目类别:
-
资助金额:$180.54万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
ERK signaling in arteriogenesis
-
批准号:10192386
-
项目类别:
-
资助金额:$56.65万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8998042
-
项目类别:
-
资助金额:$187.49万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:9766884
-
项目类别:
-
资助金额:$191.39万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8607981
-
项目类别:
-
资助金额:$186.27万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:10433814
-
项目类别:
-
资助金额:$191.22万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8214772
-
项目类别:
-
资助金额:$185.71万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
2009 Vascular Biology Gordon Research Conference
-
批准号:7588171
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Yale Cardiovascular Center faculty recruitment
-
批准号:7859426
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Yale Cardiovascular Center faculty recruitment
-
批准号:7937872
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and arterial branching
-
批准号:7322580
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and Arterial Branching
-
批准号:8470211
-
项目类别:
-
资助金额:$58.49万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and arterial branching
-
批准号:7714236
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
海外基金